Category: SF1

THE FRENCH APPROACH TO FIGHTING ANTIBIOTIC RESISTA...

Posted by admin | May 19, 2017 | 1, 2016, 2016 frontpage, Government engagement | 0

Register now

Posted by admin | May 19, 2017 | Uncategorized | 0

“Is that all?” Very little investment needed to sa...

Posted by admin | Sep 17, 2016 | Introduction | 0

Welcome

Posted by admin | Jul 11, 2016 | Introduction | 0

Introduction by Jean Carlet

Posted by admin | Apr 7, 2016 | Government engagement, Introduction | 0

2017

Responses To Antimicrobial Resistance In All Policies – The German AMR Strategy

by admin | Jul 19, 2017 | 2017, 2017 - 1, Governance | 0

Karin Knufmann-Happe, Director General For Health Protection, Disease Control and Biomedicine, Federal Ministry of Health, Germany In 2015, the German Antibiotic Resistance Strategy, DART 2020, was approved by the Federal...

MedTech Europe

by admin | May 19, 2018 | Supporters 2017 | 0
On the value of viewing Antimicrobial Resistance as a threat to international security

by admin | Jul 31, 2017 | 2017, Governance | 0
Using quality improvement to address hospital-acquired infections and antimicrobial resistance

by admin | Aug 1, 2017 | 2017, Healthcare | 0

Economics and Innovation

The Economics of reducing antibiotic use to reduce antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...

The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

2017

MedTech Europe

May 19, 2018

Institut Merieux

May 19, 2018

Less than one cent to save a patient fro...

Sep 21, 2017

A National Action Plan to Contain Antimi...

Sep 14, 2017

MedTech Europe

Sep 5, 2017

The Global Point Prevalence Survey ̵...

Jul 28, 2017

Because taking care is the essence of he...

Jul 28, 2017

Healthcare

Drug-Resistant Tuberculosis: What Is The Situation, What Are The Needs To Roll It Back?

by admin | Jul 26, 2017 | 2017, Healthcare | 0

Dr Karin Weyer, Coordinator, Laboratories, Diagnostics and Drug Resistance; Dr Dennis Falzon, Medical Officer; Dr Ernesto Jaramillo, Team Leader, Drug-Resistant TB Policies; Dr Matteo Zignol, Team Lead, Global Project on...

Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back

by admin | Jul 31, 2017 | 2017, Healthcare | 0
Intensive care units as epicentres for antimicrobial resistance development

by admin | Jul 31, 2017 | 2017, Healthcare | 0
Improving rational antibiotic treatment of common childhood conditions in Uganda

by admin | Jul 31, 2017 | 2017, Healthcare | 0

Economics and Innovation

The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Dr Christopher Houchens, Branch Chief, Antibacterial Program and Dr Joe Larsen Deputy Director, Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority, Office of Assistant Secretary for...

Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
The Economics of reducing antibiotic use to reduce antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

All

Algérie : Programme de Prévention et de Contrôle des Infections à Bactéries Multi-Résistantes en milieu de soins

by admin | Feb 18, 2019 | 4f | 0

Le réseau algérien sur la résistance aux antimicrobiens a détecté des taux élevés de pharmacorésistance montrant, par exemple, que près d’une entérobactérie sur trois était productrice d’une...